Acceleron to start trial in liver cancer patients early next year
December 03, 2013 at 13:45 PM EST
Newly-public biotech Acceleron Pharma says that it’s planning to start a trial of its cancer drug in patients with liver cancer early next year, based on promising early results of the same drug in kidney cancer patients...